Silence Therapeutics (SLN) EBITDA Margin (2024 - 2026)
Silence Therapeutics' EBITDA Margin came in at -3704.03% for the quarter ended Mar 31, 2026, up 16205.13 percentage points from -19909.15% a year earlier and up 32613.62 percentage points from the prior quarter.
Powered by 
Analysis
Silence Therapeutics (SLN) EBITDA Margin (2024 - 2026) Analysis & Trends
For the year ended Dec 31, 2025, Silence Therapeutics' EBITDA Margin was -16193.56%, down 16048.56 percentage points from the prior year.
- EBITDA Margin carries a five-year change of -15547.99 percentage points (years ended Dec 2020 to Dec 2025).
- Going back by year, EBITDA Margin was -145.00% in the year ended Dec 31, 2024 (+47.75 pp), -192.75% in the year ended Dec 31, 2023 (+82.23 pp), -274.98% in the year ended Dec 31, 2022 (+90.73 pp) and -365.71% in the year ended Dec 31, 2021 (+279.86 pp).
- The figure for the quarter ended Mar 31, 2026 represents the highest quarterly EBITDA Margin since the quarter ended Dec 31, 2024.
- Year-over-year, EBITDA Margin increased in 1 of the last five quarters, with an average year-over-year change of -12422.51 percentage points.
- Business Quant data shows SLN's EBITDA Margin at -36317.65% (quarter ended Dec 31, 2025), -16407.55% (quarter ended Sep 30, 2025) and -10631.70% (quarter ended Jun 30, 2025) in the three quarters before the quarter ended Mar 31, 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 54.65% |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 32.68% |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 46.88% |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 40.75% |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | - |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 46.62% |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 50.63% |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 42.49% |
| 10 | Silence Therapeutics | 932.92 Mn | 860.82 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -3,704.03% |
| Dec 31, 2025 | -36,317.65% |
| Sep 30, 2025 | -16,407.55% |
| Jun 30, 2025 | -10,631.70% |
| Mar 31, 2025 | -19,909.15% |
| Dec 31, 2024 | -16.64% |
| Sep 30, 2024 | -1,992.39% |
| Jun 30, 2024 | -2,904.75% |
| Mar 31, 2024 | -34.58% |
API Access
Silence Therapeutics EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=SLN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "SLN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=SLN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();